Argireline: Regulatory Status
Current legal and regulatory status for Argireline across jurisdictions. This page reflects the most recent verified information and is updated as regulatory actions occur.
Back to Argireline overviewUnited States
Gray Area
Compounding status: not applicable (cosmeceutical). WADA: not listed. marketed in 50+ countries as cosmetic ingredient. Most commercially successful anti-wrinkle peptide. Ingredient in thousands of consumer skincare products. The Ordinary's Argireline Solution 10% is a top-selling product in this category.
What This Means
Reclassification is not the same as FDA approval.
Even if Argireline moves to Category 1, it remains an off-label therapeutic that requires physician supervision. Category 1 means it can be compounded under section 503A — it does not confer approved-drug status.